Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects-Reference-Cited by-同舟云学术

Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects

Published:2018-09 Issue:6 Volume:84 Page:413-421
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

D’Souza Deepak Cyril,Carson Richard E.,Driesen Naomi,Johannesen Jason,Ranganathan Mohini,Krystal John H.,Ahn Kyung-Heup,Bielen Kimberlee,Carbuto Michelle,Deaso Emma,D’Souza Deepak Cyril,Ranganathan Mohini,Naganawa Mika,Ranganathan Mohini,D’Souza Deepak Cyril,Nabulsi Nabeel,Zheng Ming-Qiang,Lin Shu-fei,Huang Yiyun,Carson Richard E.,Driesen Naomi,Ahn Kyung-Heup,Morgan Peter T.,Suckow Raymond,He George,McCarthy Gregory,Krystal John H.,Johannesen Jason,Kenney Joshua,Gelernter Joel,Gueorguieva Ralitza,Pittman Brian

Funder

National Center for Advancing Translational Science

National Institute on Alcohol Abuse and Alcoholism

Yale Center for Clinical Investigation

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference31 articles.

1. The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia;Marder;Dialogues Clin Neurosci,2006

2. Targeting of NMDA receptors in new treatments for schizophrenia;Hashimoto;Expert Opin Ther Targets,2014

3. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels;Martina;J Physiol,2004